(Q40375552)

19 September 2017

title

Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011. (English)

1 reference

19 September 2017

4

Sacha Gnjatic

1 reference

19 September 2017

9

Lloyd J Old

1 reference

19 September 2017

8

Alexander Knuth

1 reference

19 September 2017

10

Elke Jäger

1 reference

19 September 2017

1

Julia Karbach

1 reference

19 September 2017

Claudia Pauligk

2

1 reference

19 September 2017

Armin Bender

3

1 reference

19 September 2017

Kerstin Franzmann

5

1 reference

19 September 2017

Claudia Wahle

6

1 reference

19 September 2017

Dirk Jäger

7

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

International Journal of Cancer

19 September 2017

published in

1 reference

19 September 2017

volume

118

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

668-674

1 reference

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

19 September 2017

cites work

1 reference

Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.

21 January 2018

1 reference

NY-ESO-1 expression and immunogenicity in esophageal cancer.

21 January 2018

1 reference

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

21 January 2018

1 reference

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

21 January 2018

1 reference

A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

21 January 2018

1 reference

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

21 January 2018

1 reference

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

21 January 2018

1 reference

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

21 January 2018

1 reference

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

21 January 2018

1 reference

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production

21 January 2018

1 reference

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.21391

1 reference

19 September 2017

1 reference